Canada markets closed

Astellas Pharma Inc. (ALPMY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
10.04+0.07 (+0.70%)
At close: 03:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 18.25B
Enterprise Value 22.08B
Trailing P/E 590.07
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.83
Price/Book (mrq)1.87
Enterprise Value/Revenue 0.01
Enterprise Value/EBITDA 0.13

Trading Information

Stock Price History

Beta (5Y Monthly) 0.29
52-Week Change 3-34.67%
S&P500 52-Week Change 322.38%
52 Week High 316.91
52 Week Low 39.15
50-Day Moving Average 310.43
200-Day Moving Average 312.36

Share Statistics

Avg Vol (3 month) 3332.68k
Avg Vol (10 day) 3457.47k
Shares Outstanding 51.79B
Implied Shares Outstanding 61.82B
Float 81.79B
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.45
Forward Annual Dividend Yield 44.51%
Trailing Annual Dividend Rate 370.00
Trailing Annual Dividend Yield 3702.11%
5 Year Average Dividend Yield 42.74
Payout Ratio 42,420.31%
Dividend Date 3Dec 17, 2019
Ex-Dividend Date 4Sept 28, 2023
Last Split Factor 2125:100
Last Split Date 3Apr 02, 2014

Financial Highlights

Currency in JPY.

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 1.06%
Operating Margin (ttm)-7.98%

Management Effectiveness

Return on Assets (ttm)1.80%
Return on Equity (ttm)1.10%

Income Statement

Revenue (ttm)1.6T
Revenue Per Share (ttm)894.27
Quarterly Revenue Growth (yoy)17.00%
Gross Profit (ttm)N/A
EBITDA 244.7B
Net Income Avi to Common (ttm)17.05B
Diluted EPS (ttm)0.02
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)335.69B
Total Cash Per Share (mrq)187.23
Total Debt (mrq)920.02B
Total Debt/Equity (mrq)57.65%
Current Ratio (mrq)0.93
Book Value Per Share (mrq)890.18

Cash Flow Statement

Operating Cash Flow (ttm)172.48B
Levered Free Cash Flow (ttm)109.61B